Introduction to Predictive Toxicogenomics for Carcinogenicity; Genomic Biomarkers in Cell-based Drug Screening; Toxicogenomics In Vitro: Gene Expression Signatures for Differentiating Genotoxic Mechanisms; In Vivo Signatures of Genotoxic and Non-Genotoxic Chemicals; Transcriptomic Dose-Response Analysis for Mode of Action and Risk Assessment; Using transcriptomics to evaluate thresholds in genotoxicity dose-response; Dissecting Modes of Action of Non-Genotoxic Carcinogens; Human Embryonic Stem Cells as Biological Models to Examine the Impact of Xenobiotics on the Genome and Epigenome; Novel Data Streams in the Assessment of Mutagenicity and Carcinogenicity: Implications for Cancer Hazard Assessment; Conazoles and Cancer, a Review; Application of Transcriptomics in Exposed Human Populations: Benzene as an Example; Toxicogenomics Case Study: Furan; The Parallelogram Approach to Assess Human Relevance of Toxicogenomics Derived Toxicity Pathways in Human Health Risk Assessment; Bioinformatics of Genomics in the Assessment of Cancer
